Ixinity
Product Images NDC 70504-0287

Product Visual Gallery

This gallery contains 35 technical images submitted to the FDA as part of the official labeling for Ixinity (NDC 70504-0287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aptevo Biotherapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Ixinity 01)

A two-panel instructional illustration for Ixinity. The top panel shows a hand gripping a vial with an arrow indicating to pull the cap upward. The bottom panel depicts hands peeling a protective cover from a component, likely demonstrating vial or packaging preparation steps.*

FDA Label Image

Figure B (Ixinity 02)

An instructional illustration showing how to open a two-part assembly by twisting and pulling apart the cap from a cylindrical component, likely depicting the opening of a vial or syringe component related to Ixinity by Aptevo BioTherapeutics LLC.*

FDA Label Image

Figure C (Ixinity 03)

An instructional illustration demonstrating the preparation of a medication using a syringe. One hand holds a vial or container steady, while the other hand pulls back on the syringe plunger and rotates the syringe barrel downward, indicating an action in the medication preparation process.*

FDA Label Image

Figure D (Ixinity 04)

An instructional illustration shows two hands preparing an injection. One hand holds a vial while a syringe is being pulled upwards from the vial with an arrow indicating the motion. The illustration appears to demonstrate the step of drawing medication into the syringe, related to the Ixinity product.*

FDA Label Image

Figure E (Ixinity 05)

An instructional illustration showing two hands connecting a syringe to a vial. The vial is held in one hand, while the other hand is pushing the syringe needle onto the vial's stopper, indicated by a downward arrow. This diagram likely demonstrates how to prepare or withdraw medication from the vial for the product Ixinity by Aptevo BioTherapeutics LLC.*

FDA Label Image

Figure F (Ixinity 06)

An instructional line drawing showing a hand holding a syringe and attaching it to a small vial. Arrows indicate a twisting motion to connect the syringe to the vial, demonstrating how to prepare a dose for injection.*

FDA Label Image

Figure G (Ixinity 07)

An instructional illustration showing a vial being prepared for injection. One hand holds the vial steady while the other hand pulls back the plunger of a syringe inserted into the vial, indicating the step to withdraw medication. The image is related to the preparation of Ixinity injection.*

FDA Label Image

Figure H (Ixinity 08)

Instructional diagram showing a hand holding a syringe above a vial. The other hand holds the vial steady while an arrow indicates turning or twisting the vial to open or prepare for drawing liquid into the syringe. There are no visible product names or text.*

FDA Label Image

Figure I (Ixinity 09)

An instructional illustration showing two hands operating a syringe. One hand holds the syringe barrel while the other hand presses the plunger downward, indicated by a downward arrow, demonstrating the injection or expelling of the syringe contents.*

FDA Label Image

Figure J (Ixinity 10)

An instructional illustration showing two hands assembling an injection device. One hand holds a vial upside down while the other hand holds a syringe aligned for drawing medication. An arrow indicates the direction for insertion or movement during the preparation process.*

FDA Label Image

Figure (Ixinity 11)

An instructional diagram showing three components: a vial containing powdered drug, a vial adapter, and a prefilled syringe with plunger, illustrating the equipment used for drug preparation or administration.*

FDA Label Image

Figure (Ixinity 12)

An instructional illustration showing a hand forming a fist with the thumb positioned upward and an arrow indicating the thumb is being stretched or pulled upward. The diagram appears to demonstrate a specific hand movement or technique, without text or branding.*

FDA Label Image

Figure (Ixinity 13)

An instructional diagram showing two hands demonstrating how to peel back the plastic seal from a small vial or container, likely related to preparing or accessing the Ixinity product.*

FDA Label Image

Figure (Ixinity 14)

An instructional illustration showing hands holding a syringe and a needle, depicting the step of attaching or twisting the needle onto the syringe. The image is likely part of administration instructions for Ixinity by Aptevo BioTherapeutics LLC.*

FDA Label Image

Figure (Ixinity 15)

An instructional illustration showing the preparation of a syringe for medication administration. The image depicts two hands: one holding a vial and the other using a syringe to withdraw medication by inserting the needle into the vial and pulling back the plunger. A downward arrow and a circular arrow emphasize the correct direction of syringe movement and rotation.*

FDA Label Image

Figure (Ixinity 16)

An instructional illustration showing a pair of hands preparing a syringe by drawing liquid from a vial. The vial is held on a flat surface while the syringe needle is inserted upward, indicating the step of withdrawing medication into the syringe.*

FDA Label Image

Figure (Ixinity 17)

An instructional black and white line drawing showing a person holding two pieces of a medical device, aligning them for connection. The image includes a downward arrow indicating the direction to push for assembly, illustrating part of the preparation or usage process for Ixinity.*

FDA Label Image

Figure (Ixinity 18)

An instructional illustration showing the steps to prepare a medication vial using a syringe. The image depicts a hand holding a syringe and attaching or detaching it from a vial, with arrows indicating the direction of movement.*

FDA Label Image

Figure (Ixinity 19)

An instructional illustration demonstrating the proper technique to remove a syringe cap from a vial, showing one hand holding the vial and the other hand pulling the syringe cap upward and twisting it off. The image is associated with Ixinity by Aptevo BioTherapeutics LLC.*

FDA Label Image

Figure (Ixinity 20)

An instructional illustration showing a person using their hands to prepare a syringe by turning a cap or stopper at the bottom, demonstrating the step of removing or loosening the cap prior to injection.*

FDA Label Image

Figure (Ixinity 21)

An instructional line drawing showing a hand holding a syringe and pressing a plunger down, indicated by a large downward arrow below the syringe. This appears to illustrate the step of pushing medication through the syringe, likely related to administering or preparing Ixinity.*

FDA Label Image

Figure (Ixinity 22)

An instructional illustration showing a hand holding a vial being inverted above a syringe, indicating the process of drawing medication into the syringe from the vial. The image is related to proper medication preparation technique.*

FDA Label Image

250 Iu Single-use Vial Label (Ixinity 23)

Label of Ixinity 250 IU Range injectable solution containing coagulation factor IX (recombinant). The label indicates it is for intravenous use only, single-use vial, prescription only. Manufactured by Aptevo BioTherapeutics LLC, Seattle, WA. The label includes barcode, lot, expiration, and potency fields.*

FDA Label Image

250 Iu Kit Label (Ixinity 24)

Packaging label for Ixinity coagulation factor IX (recombinant) 250 IU Range, manufactured by Aptevo BioTherapeutics LLC. The label includes storage instructions (2-8°C, do not freeze), product contents, and usage notes. It is a lyophilized powder for solution with a 10 mL syringe prefilled with 5 mL sterile water for injection. The label details the nominal potency and formulation components, along with regulatory and handling information.*

FDA Label Image

500 Iu Single-use Vial Label (Ixinity 25)

Label for Ixinity coagulation factor IX (recombinant) by Aptevo BioTherapeutics LLC. The label specifies the 500 IU range, indicates intravenous use only, single-use vial, and prescription status. Includes barcode and manufacturer details from Seattle, WA.*

FDA Label Image

500 Iu Kit Label (Ixinity 26)

Packaging label for Ixinity coagulation factor IX (recombinant) 500 IU Range. The label includes storage instructions to keep the product at 2-25°C (36-77°F), avoid freezing, and protect from light. It also states the labeler as Aptevo BioTherapeutics LLC, Seattle, WA. The label details the single-use vial contents and handling instructions. The design features blue accent blocks and the Aptevo logo.*

FDA Label Image

1000 Iu Single-use Vial Label (Ixinity 27)

Label for Ixinity coagulation factor IX (recombinant) with a strength indication of 1000 IU Range, intended for intravenous use only. The label notes it is a single-use vial, Rx only, manufactured by Aptevo BioTherapeutics LLC, Seattle, WA. Includes NDC 70504-0271-1 and a barcode.*

FDA Label Image

1000 Iu Kit Label (Ixinity 28)

Packaging label for Ixinity coagulation factor IX (recombinant) 1000 IU Range by Aptevo BioTherapeutics LLC. The label includes storage instructions (2-256F, do not freeze), contents listing (one vial with 1000 IU, vial adaptor, and syringe), and administration cautions. The label also highlights that it is a lyophilized powder for solution, intended for single-use injection only, and includes contact and licensing information.*

FDA Label Image

1000 Iu Multi-vial Kit Label (Ixinity 29)

Label for Ixinity coagulation factor IX (recombinant) showing a strength range of 1500 IU. The label indicates it is for intravenous use only, single-use vial, and Rx only. Manufactured by Aptevo BioTherapeutics LLC in Seattle, WA. Includes bar code and space for lot, expiration date, and potency information.*

FDA Label Image

1500 Iu Single-use Vial Label (Ixinity 30)

Packaging label for Ixinity coagulation factor IX (recombinant) 1500 IU Range by Aptevo BioTherapeutics LLC. The label includes storage instructions, contents, and usage information. It specifies a lyophilized powder for solution in a 10 mL syringe vial for injection, with no preservatives. The label notes proper handling precautions and manufacturer details in Seattle, WA.*

FDA Label Image

1500 Iu Kit Label (Ixinity 31)

Label for Ixinity coagulation factor IX (recombinant) injection, displaying 2000 IU range strength. The single-use vial is for intravenous use only and is manufactured by Aptevo BioTherapeutics LLC, Seattle, WA. The label includes the NDC 70504-0276-1 barcode and states RX only.*

FDA Label Image

1500 Iu Multi-vial Kit Label (Ixinity 32)

Packaging label for Ixinity coagulation factor IX (recombinant) by Aptevo BioTherapeutics LLC. The label indicates a 2000 IU range and includes storage instructions to keep between 2-25°C, away from light, and out of reach of children. It also notes that the product comes as lyophilized powder for solution with a vial adaptor and syringe for injection.*

FDA Label Image

2000 Iu Single-use Vial Label (Ixinity 33)

Ixinity coagulation factor IX (recombinant) label showing 3000 IU Range, for intravenous use only, single-use vial. Manufactured by Aptevo BioTherapeutics LLC in Seattle, WA. Includes Rx only designation, barcode, lot, expiration, and potency fields.*

FDA Label Image

2000 Iu Kit Label (Ixinity 34)

Packaging label for Ixinity, coagulation factor IX (recombinant), indicating a 3000 IU range strength. The label includes the manufacturer Aptevo BioTherapeutics LLC, Seattle, WA, and instructions for storage between 2-25°C. The label describes the product as a lyophilized powder for solution with a single vial and vial adaptor, including a 10 mL syringe prefilled with sterile water for injection.*

FDA Label Image

3000 Iu Single-use Vial Label (Ixinity 35)

Label for Water for Injection, USP, intended for reconstitution of Ixinity (coagulation factor IX [recombinant]). The label indicates the product is sterile, contains 5 mL in a single-use syringe, and is for Rx only. It includes storage instructions and manufacturing details for Aptevo BioTherapeutics LLC via Rovi Contract Manufacturing in Madrid, Spain, along with an NDC number and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.